Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: NASDAQ CM
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Drug Delivery Systems

Antares Pharma Inc

+ Add to Watchlist

ATRS:US

4.1100 USD 0.0600 1.48%

As of 20:10:00 ET on 05/24/2013.

Company Profile for Antares Pharma Inc (ATRS)

Antares Pharma, Inc. develops pharmaceutical delivery systems, including needle-free and mini-needle injector systems and transdermal gel technologies. The Company distributes its needle-free injector systems in various countries. Antares also conducts research and development with transdermal gel products and has several products in clinical evaluation with partners.

Contact Information

Antares Pharma Inc

100 Princeton South
Suite 300
Ewing, NJ 08628
United States
Phone: 1-609-359-3020

Key Executives for Antares Pharma Inc (ATRS)

Paul K WottonPresident/CEORobert F AppleExec VP/CFO/Secretary
Kaushik J DaveExec VP:Product Dev

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil